Dapagliflozin and Metformin Hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
33342-409 -
Package NDC
33342-409-06 -
Package NDC
33342-409-07 -
Package NDC
33342-409-09 -
Package NDC
33342-409-10 -
Package NDC
33342-409-15 -
Application number
ANDA211559 -
SPL ID
237ce7d1-f375-4c14-971d-a682fdccd6bf -
SPL set ID
7d575ca8-9c1f-469d-a341-34daf2f036dd -
UNII
1ULL0QJ8UC -
UNII
786Z46389E -
RxCUI
1593058 -
RxCUI
1593068 -
RxCUI
1593070 -
RxCUI
1593072
What the source publishes
- Labeler
- Macleods Pharmaceuticals Limited
- Active ingredients
- Dapagliflozin and Metformin Hydrochloride
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Dapagliflozin and Metformin Hydrochloride",
"splId": "237ce7d1-f375-4c14-971d-a682fdccd6bf",
"labels": [
{
"setId": "7d575ca8-9c1f-469d-a341-34daf2f036dd",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7d575ca8-9c1f-469d-a341-34daf2f036dd",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7d575ca8-9c1f-469d-a341-34daf2f036dd"
}
],
"routes": [
"ORAL"
],
"labeler": "Macleods Pharmaceuticals Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "3 BLISTER PACK in 1 CARTON (33342-409-06) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (33342-409-66)",
"package_ndc": "33342-409-06",
"identifierStatus": "well-formed",
"marketing_start_date": "20260406"
},
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-409-07)",
"package_ndc": "33342-409-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20260406"
},
{
"sample": false,
"description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-409-09)",
"package_ndc": "33342-409-09",
"identifierStatus": "well-formed",
"marketing_start_date": "20260406"
},
{
"sample": false,
"description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-409-10)",
"package_ndc": "33342-409-10",
"identifierStatus": "well-formed",
"marketing_start_date": "20260406"
},
{
"sample": false,
"description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-409-15)",
"package_ndc": "33342-409-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20260406"
}
],
"productId": "33342-409_237ce7d1-f375-4c14-971d-a682fdccd6bf",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "33342-409",
"deaSchedule": null,
"genericName": "Dapagliflozin and Metformin Hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DAPAGLIFLOZIN",
"strength": "10 mg/1"
},
{
"name": "METFORMIN HYDROCHLORIDE",
"strength": "1000 mg/1"
}
],
"applicationNumber": "ANDA211559",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20260406",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000187059",
"N0000187058"
],
"upc": [
"0333342409096",
"0333342406071",
"0333342407153",
"0333342406095",
"0333342409102",
"0333342408150",
"0333342407092",
"0333342406101",
"0333342408075",
"0333342407078",
"0333342409072",
"0333342406156",
"0333342408105",
"0333342409157",
"0333342408099",
"0333342407108"
],
"unii": [
"1ULL0QJ8UC",
"786Z46389E"
],
"rxcui": [
"1593058",
"1593068",
"1593070",
"1593072"
],
"spl_set_id": [
"7d575ca8-9c1f-469d-a341-34daf2f036dd"
],
"pharm_class_epc": [
"Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Sodium-Glucose Transporter 2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Macleods Pharmaceuticals Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:33342-409_237ce7d1-f375-4c14-971d-a682fdccd6bf"